Cargando…

Erratum to ‘Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients’: [ESMO Open Volume 7, Issue 1, February 2022, 100393]

Detalles Bibliográficos
Autores principales: Beechinor, R., Palumbo, A., Chew, H.K., Arora, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933809/
https://www.ncbi.nlm.nih.gov/pubmed/35306439
http://dx.doi.org/10.1016/j.esmoop.2022.100460
_version_ 1784671738512015360
author Beechinor, R.
Palumbo, A.
Chew, H.K.
Arora, M.
author_facet Beechinor, R.
Palumbo, A.
Chew, H.K.
Arora, M.
author_sort Beechinor, R.
collection PubMed
description
format Online
Article
Text
id pubmed-8933809
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89338092022-03-20 Erratum to ‘Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients’: [ESMO Open Volume 7, Issue 1, February 2022, 100393] Beechinor, R. Palumbo, A. Chew, H.K. Arora, M. ESMO Open Erratum Elsevier 2022-03-17 /pmc/articles/PMC8933809/ /pubmed/35306439 http://dx.doi.org/10.1016/j.esmoop.2022.100460 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Erratum
Beechinor, R.
Palumbo, A.
Chew, H.K.
Arora, M.
Erratum to ‘Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients’: [ESMO Open Volume 7, Issue 1, February 2022, 100393]
title Erratum to ‘Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients’: [ESMO Open Volume 7, Issue 1, February 2022, 100393]
title_full Erratum to ‘Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients’: [ESMO Open Volume 7, Issue 1, February 2022, 100393]
title_fullStr Erratum to ‘Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients’: [ESMO Open Volume 7, Issue 1, February 2022, 100393]
title_full_unstemmed Erratum to ‘Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients’: [ESMO Open Volume 7, Issue 1, February 2022, 100393]
title_short Erratum to ‘Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients’: [ESMO Open Volume 7, Issue 1, February 2022, 100393]
title_sort erratum to ‘reply to: drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients’: [esmo open volume 7, issue 1, february 2022, 100393]
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933809/
https://www.ncbi.nlm.nih.gov/pubmed/35306439
http://dx.doi.org/10.1016/j.esmoop.2022.100460
work_keys_str_mv AT beechinorr erratumtoreplytodrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatientsesmoopenvolume7issue1february2022100393
AT palumboa erratumtoreplytodrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatientsesmoopenvolume7issue1february2022100393
AT chewhk erratumtoreplytodrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatientsesmoopenvolume7issue1february2022100393
AT aroram erratumtoreplytodrugdruginteractionsbetweenpalbociclibandprotonpumpinhibitorsmaysignificantlyaffectclinicaloutcomeofmetastaticbreastcancerpatientsesmoopenvolume7issue1february2022100393